INDRAPRASTHA MEDICAL CORPORATION LT

Scale -

Revenue is 1483 Rs Cr; Continuous Growth over 3 years; 5 Year CAGR is 14 %
Ebitda is 296 Rs Cr; Continuous Growth over 3 years; 5 Year CAGR is 26 %
PAT is 184 Rs Cr; Continuous Growth over 3 years; 5 Year CAGR is 33 %
Quarterly Profit is 55.85 Rs Cr; Continuous Growth over 3 Quarters
PBT is 74.82 Rs Cr; 5 Year CAGR is 33 %

Profitability -

PBDIT Margin is 19.94 %; Continuous Growth over 3 years; 5 Year CAGR is 11 %
PAT Margin is 12.38 %; Continuous Growth over 3 years; 5 Year CAGR is 17 %
Quarterly Profit margin is 14 %; Continuous Growth over 3 Quarters; in Top Quartile

Return -

ROCE is 30.66 %; in Top Quartile
ROA is 18.52 %; in Top Quartile
ROE is 24.8 %; in Top Quartile
Asset Turnover is 161 %; in Top Quartile; Continuous Decline over 3 years

Efficiency -

Current Ratio is 2.46; Continuous Growth over 3 years
Quick Ratio is 2.41; Continuous Growth over 3 years
Inventory Turnover Ratio is 200; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 81 %
Operating cash flow is 167 Rs Cr; 5 Year CAGR is 24 %

Solvancy -

Long term Debt is 0 Rs Cr; in Bottom Quartile
Total Debt is 0 Rs Cr; in Bottom Quartile

Contingent Liabilities is 117 Rs Cr; Continuous Growth over 3 years

Quality -

Operating cashflow/ebitda is 57 %; Continuous Decline over 3 years; in Bottom Quartile
Operating cashflow/PAT is 91 %; Continuous Decline over 3 years; in Bottom Quartile
Exceptional Items/PBT is 0 %; in Top Quartile
Change in Inventories/Total Expenses is 0 %; in Top Quartile
Other Expenses/Total Expenses is 53 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector

Major Subsidiaries/Associates

Key Clients

Products

Products

Product details

Operations

Capacity/ Production

Key Facilities

Key Certifications

Raw materials

Search: